Association of mineral metabolism biomarkers with chronic kidney disease in Chinese adults

被引:4
作者
Li, Jialin [1 ,2 ]
He, Danni [3 ]
Zhao, Wenjing [2 ]
Wu, Xi'ai [4 ]
Luo, Minjing [1 ]
Wang, Ying [1 ]
Yan, Meihua [1 ]
Niu, Wenquan [3 ]
Li, Ping [1 ]
机构
[1] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Nephrol, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Chronic kidney disease; Interaction; Mineral metabolism biomarkers; Propensity score matching; Risk and severity; CKD-EPI EQUATION; PARATHYROID-HORMONE; MORTALITY RISK; CALCIUM; PREVENTION; PREVALENCE; PHOSPHORUS; DIAGNOSIS; PHOSPHATE; MDRD;
D O I
10.1007/s10157-021-02037-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background We aimed to examine the association of three mineral metabolism markers, including serum calcium, inorganic phosphorus, and intact parathyroid hormone with the risk of chronic kidney disease (CKD) at all stages. Methods This retrospective cohort study involved 3563 participants, including 3274 CKD patients and 289 healthy controls. CKD is diagnosed according to clinical guidelines from the 2012 KDIGO. Effect sizes are expressed odds ratio (OR) and 95 confidence interval (CI). Results After propensity score matching, per 0.5 mg/dL increment of inorganic phosphorus was significantly associated with 1.33-, 1.61-, and 2.85-fold increased risk of CKD at stages 1-2, 4, and 5, respectively. Regarding per 8 pg/mL increment of intact parathyroid hormone, significance was only noted for stage 5. In subsidiary analyses, the risk prediction of mineral metabolism markers under study was more evident in males and hypertensive subjects. A nomogram prediction model was constructed based on age, sex, and three mineral metabolism markers for CKD, with decent accuracy. Conclusions Our findings indicate that serum calcium was associated with all-stage CKD risk, whereas the association for inorganic phosphorus and intact parathyroid hormone was significant at advanced stages.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 34 条
[1]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc14-S081, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc13-S011, 10.2337/dc11-S062, 10.2337/dc11-S011, 10.2337/dc10-S062, 10.2337/dc12-s011, 10.2337/dc12-s064]
[2]  
[Anonymous], 2019, Am J Kidney Dis, DOI 10.1053/j.ajkd.2019.09.002
[3]   Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction [J].
Bellasi, Antonio ;
Mandreoli, Marcora ;
Baldrati, Leopoldo ;
Corradini, Matteo ;
Di Nicolo, Pierpaolo ;
Malmusi, Giulio ;
Santoro, Antonio .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04) :883-891
[4]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[5]   Hypertension in patients with CKD in China: clinical characteristics and management [J].
Cai, Guangyan ;
Chen, Xiangmei .
FRONTIERS OF MEDICINE, 2017, 11 (03) :307-309
[6]  
Chobanian AV., NATL HIGH BLOOD PRES
[7]   The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease [J].
De Boer, IH ;
Gorodetskaya, I ;
Young, B ;
Hsu, CY ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11) :2762-2769
[8]   Power and sample size calculations for studies involving linear regression [J].
Dupont, WD ;
Plummer, WD .
CONTROLLED CLINICAL TRIALS, 1998, 19 (06) :589-601
[9]   Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease [J].
Felsenfeld, Arnold J. ;
Levine, Barton S. ;
Rodriguez, Mariano .
SEMINARS IN DIALYSIS, 2015, 28 (06) :564-577
[10]   New measures against chronic kidney diseases in Japan since 2018 [J].
Fukui, Akira ;
Yokoo, Takashi ;
Nangaku, Masaomi ;
Kashihara, Naoki .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (11) :1263-1271